Sign In

Ryan Watts

CEO of Denali Therapeutics

Ryan Watts is the CEO and co-founder of Denali Therapeutics, a biotechnology company focused on developing treatments for neurodegenerative diseases.12 He has held this position since the company's inception on January 1, 2015.1

Background and Education

Watts has a strong background in neuroscience and biology:

  • He earned his Bachelor's Degree in Biology from the University of Utah (1994-2000).6
  • He obtained his Ph.D. in Biological Sciences from Stanford University (2000-2004).64

Professional Experience

Before co-founding Denali Therapeutics, Watts had a significant career at Genentech:

  • He worked at Genentech from 2004 to 2015.6
  • At Genentech, he served as Director of the Department of Neuroscience.4
  • He led the company's re-entry into neuroscience and focused on drug discovery for cancer and Alzheimer's disease.3

Leadership at Denali Therapeutics

As CEO of Denali, Watts has:

  • Led the company in advancing multiple therapeutic candidates into clinical testing for diseases like Parkinson's, Alzheimer's, and ALS.3
  • Overseen the development of a proprietary blood-brain barrier platform for delivering therapeutic proteins to the brain.3
  • Guided efforts to raise significant capital and forge partnerships to accelerate drug discovery and development.3

Personal Motivation

Watts's dedication to neurodegenerative disease research is partly driven by personal experience:

  • His mother's battle with Alzheimer's disease has influenced his mission to develop groundbreaking treatments.5
  • This personal connection underscores the urgency he feels in developing cutting-edge therapies in the field of neurodegeneration.5

Ryan Watts's leadership at Denali Therapeutics is characterized by a deep understanding of neuroscience, a commitment to innovation, and a personal drive to combat neurodegenerative diseases.

Related Questions

What are Ryan Watts's key achievements at Denali Therapeutics?
How did Ryan Watts's experience at Genentech influence his leadership at Denali?
What personal motivations drive Ryan Watts's work in neurodegenerative diseases?
How has Ryan Watts's background in neuroscience shaped his approach at Denali?
What are the main challenges Ryan Watts faces in developing treatments for neurodegenerative diseases?
Ryan Watts
Ryan Watts, photo 1
Ryan Watts, photo 2
Add to my network

Experience

CEO at Denali Therapeutics since 2015
Director at Genentech, 2004 - 2015

Education

Ph.D. in Biological Sciences, Stanford University, 2000 - 2004; Bachelor's Degree in Biology, University of Utah, 1994 - 2000

Location

South San Francisco, California, United States